EFFECTS OF CAPSAICIN ON RAT SCIATIC NERVE IN VINCRISTINE-INDUCED NEUROPATHIC PAIN MODEL

Similar documents
Potential role of Tamoxifen as a secondary analgesic for chemotherapy induced neuropathic pain

Diagnosis and Treatment of Postherpetic Neuralgia

ABSTRACT. Original Articles /

Mechanism of Pain Production

Biomechanics of Pain: Dynamics of the Neuromatrix

الاسود التعرق= Black sweat. Chromhidrosis

Post-MDT leprosy neuropathy: differentially diagnosing reactional neuritis and relapses.

INTERACTIVE QUESTIONS

TMC9 as a novel mechanosensitive ion channel

Potential for delta opioid receptor agonists as analgesics in chronic pain therapy

Seizure: the clinical manifestation of an abnormal and excessive excitation and synchronization of a population of cortical

Overactive Bladder; OAB. Aδ silent C. Adenosine triphosphate; ATP SD g n Key words

Pathophysiology of Pain

Pharmacology of Pain Transmission and Modulation

Inflammation-Induced Airway Hypersensitivity: From Ion Channels to Patients

Intracellular signalling cascades associated with TRP channels

CURRICULUM VITAE. Education: ; University of Debrecen (previously University Medical School), Debrecen, Hungary

Update on the Neurophysiology of Pain Transmission and Modulation: Focus on the NMDA-Receptor

Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20

A Review of Neuropathic Pain: From Diagnostic Tests to Mechanisms

211MDS Pain theories

Prof Wayne Derman MBChB,BSc (Med)(Hons) PhD, FFIMS. Pain Management in the Elite Athlete: The 2017 IOC Consensus Statement

Neuropathic pain, pain matrix dysfunction, and pain syndromes

International Journal of Research in Pharmacology & Pharmacotherapeutics

Sudan JMS Vol. 8, No.4. Dec

MANAGING CHRONIC PAIN

Application of a capsaicin rinse in the treatment of burning mouth syndrome

Motor and sensory nerve conduction studies

Capsaicin Responses in Heat-Sensitive and Heat-Insensitive A-Fiber Nociceptors

extremities, bilateral icd 10

Yasser Moh. Aneis, PhD, MSc., PT. Lecturer of Physical Therapy Basic Sciences Department

susceptibility of either the axons in the dorsal and ventral roots, or the intramedullary

ANAT2010. Concepts of Neuroanatomy (II) S2 2018

Neuropathic Pain in Palliative Care

Pharmacological evaluation. in human ipsc-derived cortical and sensory neurons using high-throughput MEA system

The Pain Pathway. dorsal root ganglion. primary afferent nociceptor. TRP: Transient Receptor Potential

The nervous system is responsible for most of the functions that characterize

by mapping the spinal cord in the rostro-caudal axis while recording cord dorsum

ANAT2010. Concepts of Neuroanatomy (II) S2 2018

What is pain?: An unpleasant sensation. What is an unpleasant sensation?: Pain. - Aristotle.

Capsaicin cutaneous patch

MAST CELLS IN THE TYMPANIC PART OF THE FACIAL NERVE IN CHRONIC OTITIS MEDIA WITHOUT ASSOCIATED FACIAL PARALYSIS

Title proteinase-activated receptor 2 ago. Published by Elsevier Ireland Ltd.

Pain and Touch. Academic Press. Edited by Lawrence Kruger. Department of Neurobiology University of California, Los Angeles Los Angeles, California

CHAPTER 4 PAIN AND ITS MANAGEMENT

Pain Management: A Comprehensive Review

Introduction to some interesting research questions: Molecular biology of the primary afferent nociceptor

ACTIVITY IN THE LOCUST NERVE CORD IN RESPONSE TO WING-NERVE STIMULATION

Refractory Central Neurogenic Pain in Spinal Cord Injury. Case Presentation

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

CHAPTER 10 THE SOMATOSENSORY SYSTEM

Sensory coding and somatosensory system

A role for uninjured afferents in neuropathic pain

Animal Model of Trigeminal Neuralgia Induced by Chronic Constriction Injury Applied to the Ophthalmic Nerve in the Rat

The antihyperalgesic effects of gabapentinoids, carbamazepine and its keto analogue, oxcarbazepine, in capsaicin-induced thermal hyperalgesia

Conduction abnormalities, Demyelination, Dorsal root ganglion, Experimental allergic encephalomyelitis, Lewis rat, Nerve conduction, Pathophysiology

Accepted author version posted online: 26 May 2015.

Brian Kahan, D.O. FAAPMR, DABPM, DAOCRM, FIPP Center for Pain Medicine and Physiatric Rehabilitation 2002 Medical Parkway Suite 150 Annapolis, MD

Preemptive Analgesia: Does it Prevent Chronic Pain?

GIANT FIBRE AND SMALL FIBRE PATHWAYS INVOLVED IN THE EVASIVE RESPONSE OF THE COCKROACH, PERIPLANETA AMERICANA

NORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING FOR PAIN MANAGEMENT

Chapter 34 The Nervous System:

CHAPTER 4 PAIN AND ITS MANAGEMENT

peripheral neuropathy peripheral neuropathy neuropathy peripheral neuropathy neuropathic foot heel Bilateral foot pain Bilateral heel pain bilateral

MEDICAL POLICY SUBJECT: KETAMINE INFUSION THERAPY FOR THE TREATMENT OF CHRONIC PAIN SYNDROMES POLICY NUMBER: CATEGORY: Technology Assessment

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

NMDA-Receptor Antagonists and Opioid Receptor Interactions as Related to Analgesia and Tolerance

2018 Learning Outcomes

axion Application Note Modeling Pain with Rat Dorsal Root Ganglion Neurons on MEAs BioSystems

An Evaluation of Xylene-free Processing of Tissues From the Central Nervous System Using the PelorisTM Dual Retort Rapid Tissue Processor

Explain the laboratory diagnosis of Rabies?

Repeated intra-articular injections of acidic saline produce long-lasting joint pain and. widespread hyperalgesia

SPECIAL REPORT Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints

-12. -Osama Asa ad Khader. -Ameera Almomani. - Loay Zgoul

NEURONS Chapter Neurons: specialized cells of the nervous system 2. Nerves: bundles of neuron axons 3. Nervous systems

themes G. F. GEBHART Department of Pharmacology, The University of Iowa, College of Medicine, Iowa City, Iowa 52242

Risk Factors That Predispose Patients to Orofacial Pain

Diabetic Complications Consortium

Somatosensory Physiology (Pain And Temperature) Richard M. Costanzo, Ph.D.

GENERAL PAIN DEFINITIONS

Chemotherapy-Induced Peripheral Neuropathy in Egyptian Patients: Single Institution Retrospective Analysis

Mark W. Green, MD, FAAN

Acute Pain NETP: SEPTEMBER 2013 COHORT

What Does the Mechanism of Spinal Cord Stimulation Tell Us about Complex Regional Pain Syndrome?pme_

The Egyptian Journal of Hospital Medicine (January 2018) Vol. 70 (12), Page

The biochemical origin of pain: The origin of all pain is inflammation and the inflammatory response: Inflammatory profile of pain syndromes

Study the Effects of Exposing the Skin and Eyes of Mice to Ultraviolet-C Radiation

Prevalence of neuropathic pain in Poland

S E C T I O N I M E C H A N I S M S A N D E P I D E M I O L O G Y

Skin biopsy in t of peripheral n

MOLECULAR AND CELLULAR NEUROSCIENCE

TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) Dr. Mohammed TA, Omar, PhD, PT Rehabilitation Science Department CAMS-KSU

The Potential Effect of Caffeine and Nicotine Co-administration on the Induction of Alzheimer s disease

Human Anatomy and Physiology I Laboratory

PAIN MANAGEMENT in the CANINE PATIENT

By the end of this lecture the students will be able to:

Human Anatomy and Physiology - Problem Drill 11: Neural Tissue & The Nervous System

ON RAT CUTANEOUS AFFERENT NERVE ACTIVITY

57. Trajectory o f Primary Vestibular Fibers Originating f rom the Lateral, Anterior, and Posterior Semicircular Canals in the Cat

Transcription:

IJPSR (2013), Vol. 4, Issue 2 (Research Article) Received on 17 October, 2012; received in revised form, 29 November, 2012; accepted, 30 January, 2013 EFFECTS OF CAPSAICIN ON RAT SCIATIC NERVE IN VINCRISTINE-INDUCED NEUROPATHIC PAIN MODEL Thanaa A. El-Masry * 1, Magda E. El Sayaad 1, Ibrahim A. Gaaboub 2 and Wafaa M. Fouda 1 Department of Pharmacology & Toxicology, Faculty of Pharmacy, Tanta University 1, Egypt Department of Plant Protection, Faculty of Agriculture, Banha University 2, Egypt Keywords: Capsaicin, Vincristine, Electrophysiology, Neuropathic Pain Correspondence to Author: Thanaa A. El-Masry Department of Pharmacology & Toxicology, Faculty of Pharmacy, Tanta University, Egypt E-mail: fofo_pharm2007@yahoo.com ABSTRACT Capsaicin, the pungent ingredient of red pepper, is used topically to treat different types of neuropathic pain, in rat model of vincristine induced neuropathic pain we tried to investigate the effect of capsaicin on sciatic nerve through electrophysiological and histopathological studies. We found that treatment of animals with vincristine results in significant decrease in sciatic nerve conduction velocity and degeneration of the nerve fibers, where combined treatment of vincristine and capsaicin showed highly significant decrease in sciatic nerve conduction velocity and degeneration of the nerve fibers compared with that treated with vincristine only. In new trial, we tried to investigate the effect of direct capsaicin titration on sciatic nerve fibers that results in nearly abolishment of nerve conduction velocity. All of these findings may illustrate the mechanism of capsaicin effect through afferent nerves degeneration. INTRODUCTION: The pungent ingredient of red pepper, Capsaicin, is used topically in treatment of post-hepatic neuralgia, diabetic neuropathy and osteoarthritis 1. Capsaicin therapeutic effects are based on modification of sensory nerve endings. Capsaicin renders animals and man insensitive to further noxious stimuli after initial irritation 2. Examination of the function of sensory neurons specifically peripheral C- fibers can be mediated by capsaicin.it was found that capsaicin high doses cause desensitization to chemical stimuli, loss of neurogenic inflammation, and depletion of neuropeptides. Analgesic (and anti-inflammatory) effects of capsaicin can be accounted for by a rapid degeneration/ destruction of sensory ganglion cell axons and/or peripheral and central axon terminals, these effects were suggested due to the rapid onset and the long 3, 4, 5, duration of the antinociceptive effect of vanilloids 6, 7. Indeed, independent laboratories experimental data support the notion that capsaicin antinociceptive effects, administered through different routes, are associated with degenerative changes within the different domains of the nociceptive primary sensory neuron and the consequent loss of peripheral or central nociceptor specific macromolecules and receptors 4, 8. One of the most common chemotherapeutic drugs used to treat various types of malignancies is vincristine 9, 10. Its major dose-limiting side effect is neurotoxicity that requires discontinuation of treatment and thus greatly affects the survival of cancer patients 11, 12, 13. In this study, we investigate the degenerative effects of capsaicin on sciatic nerve by systemic repeated doses of capsaicin in vincristine induced neuropathy model through electrophysiological study and histopathological examination of sciatic nerve. Available online on www.ijpsr.com 666

MATERIAL AND METHODS: 1. Animals: Fifteen female Egyptian rats (140-160 g).rats were housed in groups of five under a 12-h light/dark cycle. Food and water were available. Experiments were carried out in accordance with NIH regulations for animal care and with the approval of the Institutional Animal Care and Use Committee of the University of California, San Francisco. All efforts were made to minimize the number of animals used and their suffering. 2. Drugs: Vincristine-treated group: Vincristine (Vincristine Pierre Fabre1 1 mg/ml, Boulogne, France) was diluted in normal saline (NaCl 0.9%, Braun, Melsungen, Germany) just before administration to give a final concentration between 50 and 100 mg/ml, depending on the animal weight and ensuring that volumes of less than 1 ml would be injected I.P. Capsaicin-treated group: Capsaicin dissolved in (10% methanol + 10% tween 80 and 80% D.W) Solvent. Control groups: Injected volumes of saline (NaCl 0.9%) were calculated according to the weight of the rat. 3. Experimental Procedures: Animals were classified into 3 groups Vincristine- treated group: Vincristine was administered I.P. every 2 days until five injections had been given 150 mg/kg (cumulative dose: 750 mg/kg). To avoid acute effects the injections were given after the behavioral tests were performed. Capsaicin treated group: Rats were I.P. injected with Vincristine dose (150µg/kg) once every 2 days till 5 injections with Capsaicin I.P. (500µg/kg) once every 2 days 30 minutes before each Vincristine injection till 7 injections. Control group: animals will be injected with volumes of normal saline according to body weight. 4. Electrophysiological study: Rats were initially anesthetized by ether inhalation as induction anesthesia for approximately 5 minutes and then mounted in plasticine, ventral side up, with four legs immobilized by hooks in plasticine. Extracellular activity of the nerve was recorded with suction electrode from the sciatic nerve. Recording from the sciatic nerve was done using the extracellular recording technique 14 (Andrew 1972). The suction electrode containing the saline (0.9% NaCl) was placed over the sciatic nerve. The signals of the nerve were amplified by an AC amplifier, filtered, then displayed on an Tektronic 502 Oscilloscope and recorded on a magnetic tape. 5. Statistical analysis: The data are expressed as means SE, significance of differences between groups was assessed with Student s t-test (comparison of two groups). Significance was adopted at p<0.05 for interpretation of results of tests of significance. 6. Histology: Samples of sciatic nerve were processed and paraffin embedded sections cut at 3-5 mm thickness on glass and charged slides for routine hematoxylin and eosin staining method for light microscopy examination. RESULTS: As shown in figure 1 and 2, treatment of rats with Vincristine (150µg/kg) showed a significant decrease in sciatic nerve conduction velocity as compared to that of the control ( saline) group. Treatment of rats with (Vincristine (150µg/kg) + Capsaicin (500µg/kg) ) showed a significant decrease in nerve conduction velocity as compared to that of the Vincristine (150µg/kg) treated group. Direct Capsaicin titration on sciatic nerve in(vincristine (150µg/kg) + Capsaicin (500µg/kg)) treated animals showed significant decrease in nerve conduction velocity compared to (Vincristine (150µg/kg) + Capsaicin (500µg/kg)). Washing the nerve with normal saline after capsaicin titration resulted in a significant increase in the nerve conduction velocity. As shown in figure 3 histopathological examination of sciatic nerve section of animals treated with Vincristine (150µg/kg) showed degenerated sciatic nerve fibers and perineuronal mononuclear cell infiltrations. Combined treatment of rats with (Vincristine (150µg/Kg) and Capsaicin (500µg/kg) showed sciatic nerve fibers section with degenerated myelin (vacuolar degeneration). Available online on www.ijpsr.com 667

A B C (d) FIGURE 1: SPIKE DISCHARGES IN SCIATIC NERVE OF RAT IN RESPONSE TO :NORMAL SALINE (A), VINCRISTINE (B), CAPSAICIN (C), CAPSAICIN WITH DIRECT CAPSAICIN TITRATION ON THE NERVE (D) Available online on www.ijpsr.com 668

DISCUSSION: In new animal model of neuropathic pain, vincristine, antineoplastic agent, used to induce sciatic nerve injury. Capsaicin the main agonist of transient receptor potential vanilloid 1(trpv1) used as repeated systemic doses as analgesic for vincristine induced neuropathic pain. FIGURE 2: EFFECT OF DIFFERENT DRUG TREATMENTS ON SPIKE FREQUENCIES A B C FIGURE 3: PHOTOMICROGRAPH OF HISTOPATHOLOGICAL EXAMINATION OF DIFFERENT DRUG TREATMENTS: NORMAL SALINE (A), VINCRISTINE (B) OR CAPSAICIN (C) In this study, we tried to investigate the effect of capsaicin on rat sciatic nerve through electrophysiological study and histopathological examination of the nerve. The results showed that vincristine treatment alone resulted in a significant decrease in sciatic nerve conduction velocity as compared to that of the control (saline) group representing (51.71 % of control saline value). While combined treatment of animals with vincristine and capsaicin resulted in highly significant decrease in sciatic nerve conduction velocity compared with vincristine treated only representing (10.55% of vincristine treated only value, 5.46% of control saline value). Direct capsaicin titration on sciatic nerve nearly abolished the nerve conduction velocity representing (0.00011% of control saline value). These results was confirmed by histopathological examination of sciatic nerve that showed different degrees of nerve damage where vincristine treatment showed degenerated sciatic nerve fibers and perineuronal mononuclear cell infiltrations and combined treatment of animals with vincristine and capsaicin resulted in sciatic nerve fibers section with degenerated myelin (vacuolar degeneration). Our results were agree with who found that treatment of vincristine (150µg/kg) resulted in significant decrease in sciatic nerve conduction velocity (P < 0:05, 23%) and sciatic nerve fibers with various degrees of axonal degeneration microscopically. All of these finding showed the degenerative effect of 3, 4, 6, 7 capsaicin on sciatic nerve fibers in agree with who reported that the rapid onset and the long duration of the antinociceptive effect of vanilloids have led to the suggestion that the analgesic (and antiinflammatory) effects of capsaicin may be accounted for by a rapid degeneration/ destruction of sensory ganglion cell axons and/or peripheral and central axon terminals. 14 Available online on www.ijpsr.com 669

CONCLUSION: In conclusion, vincristine treatment results in sciatic nerve injury with induction of neuropathic pain. Capsaicin was used as an analgesic for vincristine induced neuropathic pain as it cause nearly total destruction of afferent nerves. REFERENCE: 1. Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in postherpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging. 1995; (7):317 28 2. Carpenter SE, Lynn B. Vascular and sensory responses of human skin to mild injury after topical treatment with capsaicin. Br J Pharmacol. 1981; (73): 755 8. 3. Jancso G, Kira ly E, Jancso -Ga bor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature. 1977; (270): 741 743. 4. Jancso G. Pathobiological reactions of C-fibre primary sensory neurones to peripheral nerve injury. Exp Physiol. 1992; (77): 405 431. 5. Simone DA, Nolano M, Johnson T,Wende lschafer-crabb G, Kennedy WR. Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci. 1998; 18: 8947 8959. 6. Dux M, Sann H, Schemann M, Jancso G. Changes in fibre populations of the rat hairy skin following selective chemodenervation by capsaicin. Cell Tissue Res. 1999; (296): 471 477. 7. Jancso N, Desensitization with capsaicin and related acylamides as a tool for studying the function of pain receptors. In: R.K.M. Lim (Ed.). Pharmacology of Pain, Pergamon Press, Oxford, 33-55. Ref Type: Generic. 8. Nagy I, Sa ntha P, Jancso G, Urba n L. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol. 2004; (500): 351 369. 9. Postma TJ, Benard BA, Huijgens PC, Ossenkoppele GJ, Heimans JJ. Long term effects of vincristine on the peripheral nervous system. J Neuro- Onocol. 1993; (15):23 27. 10. Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 agonist) therapy for pain relief: farewell or revival? Clin J Pain. 2008; (24):142 154. 11. Sandler SG, Tobin W, Henderson ES. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology. 1969; (19):367 374. 12. Weiden PL, Wright SE. Vincristine neurotoxicity. N Eng l J Med. 1972; (286):1369 1370. 13. Andrew BI. Experimental physiology. Churchill Livingstone, London. 1972, 17-34. 14. Nicolas Authier, Jean-Pierre Gillet et al. A new animal model of vincristine-induced nociceptive peripheral neuropathy. Neurotoxicol. 2003; (24):797-805. How to cite this article: El-Masry TA, El Sayaad ME, Gaaboub IA and Fouda WM: Effects of Capsaicin on Rat Sciatic Nerve in Vincristine-induced Neuropathic Pain Model. Int J Pharm Sci Res. 2013; 4(2); 666-670. Available online on www.ijpsr.com 670